bulion t.s.y.e.b. (tryptone soya yeast extract broth)
sc sanimed international impex srl -
mediu t.s.a. (tryptone soya agar)
societatea nationala "institutul pasteur" sa -
bulion t.s.y.e.b. (tryptone soya yeast extract broth)
societatea nationala "institutul pasteur" sa -
agar t.s.y.e.a. (tryptone soya yeast extract agar)
societatea nationala "institutul pasteur" sa -
agar t.s.y.e.a. (tryptone soya yeast extract agar)
sc sanimed international impex srl -
ideos 500 mg/400 ui comprimate masticabile
laboratoire innotech international - calciu carbonas + cholecalciferolum - comprimate masticabile - 500 mg/400 ui
sotalol al 160
stada arzneimittel ag - germania - sotalolum - compr. - 160mg - medicamente betablocante betablocante neselective
sotalol al 80
stada arzneimittel ag - germania - sotalolum - compr. - 80mg - medicamente betablocante betablocante neselective
sotagamma 80 mg
artesan pharma gmbh & co. kg - germania - sotalolum - compr. - 80mg - medicamente betablocante betablocante neselective
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - agenți antineoplazici - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.